Olympus Biotech launches drug and biologic CMO

- Last updated on GMT

Olympus launches CMO
The CMO sector welcomed its newest member this week with Olympus Biotech launching a drug contract manufacturing business.

The new service – at Olympus’ facility in Lebanon, New Hampshire – will cater for pharmas and biopharmas with capabilities to make batches of drugs and biologics for clinical assessment and commercial supply.

Peter Gariepy, VP of operations, said: “The increasing number of monoclonal antibodies and recombinant proteins in the market and in development has fueled a need for experienced, sophisticated manufacturing partners that can support pre-clinical through commercial production.”

The move is something of a departure for Olympus Biotech - which is part of global manufacturing group Olympus – which previously focused the production of regenerative bone graft implants and materials.

Related topics: Contract Manufacturing

Related news

Show more